Co-Authors
This is a "connection" page, showing publications co-authored by Paolo Ascierto and Gerardo Botti.
Connection Strength
2.358
-
Immunotherapy may protect cancer patients from SARS-CoV-2 infection: a single-center retrospective analysis. J Transl Med. 2021 03 31; 19(1):132.
Score: 0.234
-
Correction to: New paradigm for stage III melanoma: from surgery to adjuvant treatment. J Transl Med. 2019 Sep 18; 17(1):315.
Score: 0.211
-
PD-L1 expression with immune-infiltrate evaluation and outcome prediction in melanoma patients treated with ipilimumab. Oncoimmunology. 2018; 7(12):e1405206.
Score: 0.196
-
Perspectives in melanoma: Meeting report from the Melanoma Bridge (30 November-2 December, 2017, Naples, Italy). J Transl Med. 2018 07 21; 16(1):207.
Score: 0.194
-
HOTAIR role in melanoma progression and its identification in the blood of patients with advanced disease. J Cell Physiol. 2017 Dec; 232(12):3422-3432.
Score: 0.180
-
COX-2 expression positively correlates with PD-L1 expression in human melanoma cells. J Transl Med. 2017 02 23; 15(1):46.
Score: 0.176
-
Mucosal melanoma of the head and neck. Crit Rev Oncol Hematol. 2017 Apr; 112:136-152.
Score: 0.176
-
Genetic instability and increased mutational load: which diagnostic tool best direct patients with cancer to immunotherapy? J Transl Med. 2017 01 21; 15(1):17.
Score: 0.175
-
Immunological and biological changes during ipilimumab treatment and their potential correlation with clinical response and survival in patients with advanced melanoma. Cancer Immunol Immunother. 2014 Jul; 63(7):675-83.
Score: 0.144
-
Clinical Outcome Prediction in COVID-19 Patients by Lymphocyte Subsets Analysis and Monocytes' iTNF-a Expression. Biology (Basel). 2021 Aug 01; 10(8).
Score: 0.060
-
Could asymptomatic carriers spread the SARS-CoV-2 infection? Experience from the Italian second wave. J Transl Med. 2021 03 02; 19(1):93.
Score: 0.058
-
Evaluation of the diagnostic accuracy of a new point-of-care rapid test for SARS-CoV-2 virus detection. J Transl Med. 2020 12 21; 18(1):488.
Score: 0.057
-
The clinical and translational research activities at the INT - IRCCS "Fondazione Pascale" cancer center (Naples, Italy) during the COVID-19 pandemic. Infect Agent Cancer. 2020 Nov 23; 15(1):69.
Score: 0.057
-
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial. J Transl Med. 2020 10 21; 18(1):405.
Score: 0.057
-
TOCIVID-19 - A multicenter study on the efficacy and tolerability of tocilizumab in the treatment of patients with COVID-19 pneumonia. Study protocol. Contemp Clin Trials. 2020 11; 98:106165.
Score: 0.057
-
BRAF Mutations and Dysregulation of the MAP Kinase Pathway Associated to Sinonasal Mucosal Melanomas. J Clin Med. 2019 Oct 01; 8(10).
Score: 0.053
-
Mutational concordance between primary and metastatic melanoma: a next-generation sequencing approach. J Transl Med. 2019 08 28; 17(1):289.
Score: 0.052
-
Genetic alterations in main candidate genes during melanoma progression. Oncotarget. 2018 Feb 02; 9(9):8531-8541.
Score: 0.047
-
Immune Checkpoint Inhibitors in Melanoma and HIV Infection. Open AIDS J. 2017; 11:91-100.
Score: 0.046
-
Are tumor-infiltrating lymphocytes protagonists or background actors in patient selection for cancer immunotherapy? Expert Opin Biol Ther. 2017 06; 17(6):735-746.
Score: 0.044
-
miR-579-3p controls melanoma progression and resistance to target therapy. Proc Natl Acad Sci U S A. 2016 08 23; 113(34):E5005-13.
Score: 0.042
-
Electrochemotherapy in melanoma patients: a single institution experience. Melanoma Manag. 2015 May; 2(2):127-132.
Score: 0.039